The Claim
In critically ill patients with COVID-19, intravenous vitamin C administered at 1.5 grams every 6 hours for up to 4 days is not associated with a reduction in Sequential Organ Failure Assessment (SOFA) score improvement compared to matched controls.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In critically ill patients with COVID-19, receiving intravenous vitamin C at 1.5 grams every six hours for up to four days does not lead to greater improvement in organ function scores compared to patients who did not receive this treatment.
See the scientific wording
In critically ill patients with COVID-19, intravenous vitamin C at 1.5 grams every 6 hours for up to 4 days is not associated with a reduction in Sequential Organ Failure Assessment (SOFA) score improvement, as post-treatment scores remain significantly higher than in matched controls.
High doses of vitamin C do not reduce the overwhelming oxidative stress in critically ill patients, so damaged cells and tissues remain under constant chemical attack, preventing organs from recovering.
What the research says
1 studyStudy: Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection
In very sick COVID-19 patients, giving high doses of IV vitamin C didn’t help their organs recover — their organ damage scores were actually worse than in patients who didn’t get the vitamin C.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.